554 related articles for article (PubMed ID: 27989510)
1. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
Huang Q; Sun ML; Chen Y; Li XY; Wang YX
J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
[TBL] [Abstract][Full Text] [Related]
2. Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.
Huang Q; Mao XF; Wu HY; Li TF; Sun ML; Liu H; Wang YX
J Neuroinflammation; 2016 Aug; 13(1):214. PubMed ID: 27577933
[TBL] [Abstract][Full Text] [Related]
3. Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia.
Li TF; Fan H; Wang YX
J Pain; 2016 May; 17(5):530-48. PubMed ID: 26762790
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.
Vanderah TW; Gardell LR; Burgess SE; Ibrahim M; Dogrul A; Zhong CM; Zhang ET; Malan TP; Ossipov MH; Lai J; Porreca F
J Neurosci; 2000 Sep; 20(18):7074-9. PubMed ID: 10995854
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between intrathecal ginsenosides and morphine on formalin-induced nociception in rats.
Yoon MH; Kim KS; Lee HG; Kim CM; Kim WM; Choi JI; Kim YO
J Pain; 2011 Jul; 12(7):774-81. PubMed ID: 21459679
[TBL] [Abstract][Full Text] [Related]
6. Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression.
Sun ML; Ao JP; Wang YR; Huang Q; Li TF; Li XY; Wang YX
Psychopharmacology (Berl); 2018 Sep; 235(9):2559-2571. PubMed ID: 29926144
[TBL] [Abstract][Full Text] [Related]
7. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Song ZH; Takemori AE
Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
[TBL] [Abstract][Full Text] [Related]
8. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408.
Milne B; Jhamandas K; Sutak M; Grenier P; Cahill CM
Eur J Pharmacol; 2014 Nov; 743():89-97. PubMed ID: 25242119
[TBL] [Abstract][Full Text] [Related]
9. Lemairamin, isolated from the Zanthoxylum plants, alleviates pain hypersensitivity via spinal α7 nicotinic acetylcholine receptors.
Wang ZY; Han QQ; Deng MY; Zhao MJ; Apryani E; Shoaib RM; Wei DQ; Wang YX
Biochem Biophys Res Commun; 2020 May; 525(4):1087-1094. PubMed ID: 32184015
[TBL] [Abstract][Full Text] [Related]
10. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
12. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
[TBL] [Abstract][Full Text] [Related]
13. Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
Zhang R; Xu B; Zhang Q; Chen D; Zhang M; Zhao G; Xu K; Xiao J; Zhu H; Niu J; Li N; Fang Q
Eur J Pharmacol; 2020 Aug; 880():173169. PubMed ID: 32416184
[TBL] [Abstract][Full Text] [Related]
14. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
15. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
Song SH; Takemori AE
Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
[TBL] [Abstract][Full Text] [Related]
16. Protopanaxadiol alleviates neuropathic pain by spinal microglial dynorphin A expression following glucocorticoid receptor activation.
Shoaib RM; Ahmad KA; Wang YX
Br J Pharmacol; 2021 Aug; 178(15):2976-2997. PubMed ID: 33786848
[TBL] [Abstract][Full Text] [Related]
17. Alterations in nociception and morphine antinociception in mice fed a high-fat diet.
Nealon CM; Patel C; Worley BL; Henderson-Redmond AN; Morgan DJ; Czyzyk TA
Brain Res Bull; 2018 Apr; 138():64-72. PubMed ID: 28684345
[TBL] [Abstract][Full Text] [Related]
18. Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine.
Liu NJ; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 Aug; 322(2):654-60. PubMed ID: 17488879
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
20. Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats.
Ambriz-Tututi M; Rocha-González HI; Castañeda-Corral G; Araiza-Saldaña CI; Caram-Salas NL; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2009 Oct; 619(1-3):25-32. PubMed ID: 19686723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
